These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4070644

  • 1. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E, Eskola J, Ruuskanen O, Laine T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [Abstract] [Full Text] [Related]

  • 2. Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders.
    Cosyns P, Maes M, Vandewoude M, Stevens WJ, De Clerck LS, Schotte C.
    J Affect Disord; 1989; 16(1):41-8. PubMed ID: 2521650
    [Abstract] [Full Text] [Related]

  • 3. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A, Holsboer F.
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [Abstract] [Full Text] [Related]

  • 4. Dexamethasone effects on numbers of cells in lymphocyte subpopulations: changes associated with major depression and DST nonsuppression.
    Pedersen CA, Folds JD, Evans DL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):895-906. PubMed ID: 2813807
    [Abstract] [Full Text] [Related]

  • 5. Stress lymphocytes and the dexamethasone suppression test in major depressive disorders.
    Miyauchi K, Hirata-Hibi M, Hashimoto M, Hosokawa K.
    Biol Psychiatry; 1989 Apr 15; 25(8):1021-8. PubMed ID: 2720015
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE, Ettigi P.
    Clin Pharm; 1983 Apr 15; 2(6):538-45. PubMed ID: 6140096
    [Abstract] [Full Text] [Related]

  • 7. Depression, cortisol metabolism and lymphocytopenia.
    Kronfol Z, Nasrallah HA, Chapman S, House JD.
    J Affect Disord; 1985 Sep 15; 9(2):169-73. PubMed ID: 2932491
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
    Arch Gen Psychiatry; 1987 Sep 15; 44(9):790-5. PubMed ID: 3632252
    [Abstract] [Full Text] [Related]

  • 9. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B, Sherman B, Schlechte J, Stone R.
    Arch Gen Psychiatry; 1985 Sep 15; 42(9):897-903. PubMed ID: 2994590
    [Abstract] [Full Text] [Related]

  • 10. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.
    Maes M, Bosmans E, Suy E, Minner B, Raus J.
    Br J Psychiatry; 1989 Dec 15; 155():793-8. PubMed ID: 2620206
    [Abstract] [Full Text] [Related]

  • 11. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL, Nemeroff CB, Haggerty JJ, Pedersen CA.
    Psychoneuroendocrinology; 1987 Dec 15; 12(3):203-9. PubMed ID: 3615749
    [Abstract] [Full Text] [Related]

  • 12. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF, Flegel P, Haskett R, Dilsaver S, Carroll BJ, Grunhaus L, Genero N.
    Psychoneuroendocrinology; 1986 Dec 15; 11(2):195-204. PubMed ID: 3749402
    [Abstract] [Full Text] [Related]

  • 13. What does the dexamethasone suppression test identify?
    Krishnan KR, France RD, Pelton S, McCann UD, Manepalli AN, Davidson JR.
    Biol Psychiatry; 1985 Sep 15; 20(9):957-64. PubMed ID: 4027315
    [Abstract] [Full Text] [Related]

  • 14. A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients.
    Maes M, Bosmans E, Suy E, Minner B, Raus J.
    Psychol Med; 1991 May 15; 21(2):313-20. PubMed ID: 1876636
    [Abstract] [Full Text] [Related]

  • 15. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar 15; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H.
    J Affect Disord; 1985 Sep 15; 9(2):121-6. PubMed ID: 2932484
    [Abstract] [Full Text] [Related]

  • 17. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL, Price LH, Charney DS, Heninger GR.
    Psychiatry Res; 1985 May 15; 15(1):5-15. PubMed ID: 2989963
    [Abstract] [Full Text] [Related]

  • 18. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA, Monteiro MG, Laranjeira RR, Jorge MR, Masur J.
    Biol Psychiatry; 1985 Nov 15; 20(11):1156-60. PubMed ID: 4052517
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
    Psychiatry Res; 1985 Jun 15; 15(2):153-8. PubMed ID: 3862146
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
    Psychiatry Res; 1983 Feb 15; 8(2):111-7. PubMed ID: 6574529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.